ESC 365 - Doctor Mariana Tinoco

Speaker illustration

Doctor Mariana Tinoco

Alto Ave Hospital Center, Guimaraes (Portugal)

Member of:

Presentations Articles

The effects of Sacubitril-Valsartan on ICD indication in patients with heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

Left ventricular reverse remodelling and prognosis of patients treated with SGLT2 inhibitors for heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

A single center study of patients who suffered cardiac arrest with a presumed diagnosis of acute coronary syndrome.

Event: Heart Failure 2022

Topic: Pathophysiology and Mechanisms

Session: Heart Failure ePosters - focus on CAD / CSS / ACS / ACC

Sacubitril-Valsartan versus ACEI in left ventricular reverse remodelling and in cardiovascular outcomes.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 8

Predictors of Sacubitril-Valsartan target dose achievement in a real-world population.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 9

Safety and effectiveness of Sacubitril-Valsartan in a real-world population.

Event: Heart Failure 2022

Topic: Pharmacotherapy

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Left ventricular diastolic function in patients with breast cancer under chemotherapy

Event: ESC Acute CardioVascular Care 2022

Topic: Imaging

Session: e-Posters session

Comparison of major adverse cardiovascular events between sacubitril-valsartan versus ACEI/ARB therapy in patients with heart failure with reduced ejection fraction

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

Predictors of major adverse cardiovascular events in patients with heart failure with reduced ejection fraction

Event: ESC Acute CardioVascular Care 2022

Topic: Epidemiology, Prognosis, Outcome

Session: e-Posters session

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources